There are still issues with this approach, although they're a bit more subtle. Think about Valeant circa 2015 -- definitely taking a short term approach of acqu

There are still issues with this approach, although they're a bit more subtle. Think about Valeant circa 2015 -- definitely taking a short term approach of acquiring and stripping pharma companies, which did positively impact their stock price. But, they did it in an unsustainable manner.